Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Selling ResMed Inc. (RMD)

Page 1 of 2

ResMed Inc. (NYSE:RMD) was in 10 hedge funds’ portfolio at the end of March. RMD has experienced a decrease in enthusiasm from smart money in recent months. There were 14 hedge funds in our database with RMD holdings at the end of the previous quarter.

ResMed Inc. (NYSE:RMD)At the moment, there are plenty of gauges market participants can use to monitor stocks. A duo of the most underrated are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the elite investment managers can trounce their index-focused peers by a significant amount (see just how much).

Equally as key, positive insider trading sentiment is another way to parse down the marketplace. Obviously, there are plenty of stimuli for an upper level exec to downsize shares of his or her company, but just one, very obvious reason why they would behave bullishly. Several academic studies have demonstrated the impressive potential of this strategy if shareholders understand where to look (learn more here).

Now, it’s important to take a peek at the recent action surrounding ResMed Inc. (NYSE:RMD).

How have hedgies been trading ResMed Inc. (NYSE:RMD)?

At the end of the first quarter, a total of 10 of the hedge funds we track were long in this stock, a change of -29% from the first quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists an “upper tier” of noteworthy hedge fund managers who were boosting their holdings substantially.

When looking at the hedgies we track, AQR Capital Management, managed by Cliff Asness, holds the largest position in ResMed Inc. (NYSE:RMD). AQR Capital Management has a $15 million position in the stock, comprising 0.1% of its 13F portfolio. On AQR Capital Management’s heels is Peter Rathjens, Bruce Clarke and John Campbell of Arrowstreet Capital, with a $14.4 million position; 0.1% of its 13F portfolio is allocated to the company. Remaining hedgies that are bullish include Anand Parekh’s Alyeska Investment Group, Chuck Royce’s Royce & Associates and Israel Englander’s Millennium Management.

Due to the fact that ResMed Inc. (NYSE:RMD) has witnessed a declination in interest from the entirety of the hedge funds we track, logic holds that there is a sect of money managers who sold off their full holdings at the end of the first quarter. At the top of the heap, Jim Simons’s Renaissance Technologies cut the largest position of the “upper crust” of funds we watch, valued at an estimated $22.6 million in stock.. Andy Redleaf’s fund, Whitebox Advisors, also sold off its stock, about $0.8 million worth. These transactions are important to note, as total hedge fund interest dropped by 4 funds at the end of the first quarter.

Insider trading activity in ResMed Inc. (NYSE:RMD)

Insider purchases made by high-level executives is most useful when the company in question has experienced transactions within the past 180 days. Over the last six-month time period, ResMed Inc. (NYSE:RMD) has experienced zero unique insiders buying, and 11 insider sales (see the details of insider trades here).

Let’s go over hedge fund and insider activity in other stocks similar to ResMed Inc. (NYSE:RMD). These stocks are Sirona Dental Systems, Inc. (NASDAQ:SIRO), Smith & Nephew plc (ADR) (NYSE:SNN), Edwards Lifesciences Corp (NYSE:EW), Varian Medical Systems, Inc. (NYSE:VAR), and Hologic, Inc. (NASDAQ:HOLX). This group of stocks are the members of the medical appliances & equipment industry and their market caps are similar to RMD’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!